{
  "id": "737a2026b10e0d9d",
  "title": "Head to Head Contrast : Perspective Therapeutics ( NASDAQ : CATX ) & Carlsmed ( NASDAQ : CARL ) ",
  "description": "20260108T083000Z",
  "content": "",
  "source": "dailypolitical.com",
  "source_url": "https://www.dailypolitical.com/2026/01/07/head-to-head-contrast-perspective-therapeutics-nasdaqcatx-carlsmed-nasdaqcarl.html",
  "published_at": "20260108T083000Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.dailypolitical.com/2026/01/07/head-to-head-contrast-perspective-therapeutics-nasdaqcatx-carlsmed-nasdaqcarl.html",
    "url_mobile": "",
    "title": "Head to Head Contrast : Perspective Therapeutics ( NASDAQ : CATX ) & Carlsmed ( NASDAQ : CARL ) ",
    "seendate": "20260108T083000Z",
    "socialimage": "",
    "domain": "dailypolitical.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}